Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26948675 | 0.94 | SMN1; SMN2 (0.38) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL14062570 | 0.85 | TSHR (0.30) | SMN1; SMN2TSHR | |
| SCHEMBL20548535 | 0.85 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL312355 | 0.83 | SMN1; SMN2 (0.42) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL10357275 | 0.82 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL29030085 | 0.82 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL26948692 | 0.82 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL7917304 | 0.81 | — | — | |
| SCHEMBL14063423 | 0.81 | TSHR (0.31) | SMN1; SMN2TSHR | |
| Perfluorotoluene SCHEMBL308464 | 0.79 | SMN1; SMN2 (0.41) | SMN1; SMN2TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431706-A | Fatigue-resistant polyurethane elastomer and preparation method and application thereof | 万勋科技(深圳)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118084634-A | Preparation method of fluorine-containing ether and fluorine-containing ether | 纯钧新材料(深圳)有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-9815809-B2 | Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of phenols or thiophenols | DSM IP ASSETS B.V. (NL) | 2017-11-14 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-4960539-A | Use of fluoromethylphenols as solvents for LC-polymers, and new fluoromethylphenols | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| WO-2025070077-A1 | CURABLE RESIN COMPOSITION, CURED ARTICLE, AND OPTICAL WAVEGUIDE | DIC株式会社 | 2025-04-03 | — | — | WO | disclosed |
| CN-119431706-A | Fatigue-resistant polyurethane elastomer and preparation method and application thereof | 万勋科技(深圳)有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20240231222-A1 | PHOTORESIST COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-12029120-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| CN-118084634-A | Preparation method of fluorine-containing ether and fluorine-containing ether | 纯钧新材料(深圳)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240155942-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-5604213-A | STEROID DEPENDENT CANCERS SUCH AS PROSTATE AND BREAST CANCER | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-02-18 | — | — | US | disclosed |
| EP-0633893-A1 | 17-SUBSTITUTED STEROIDS USEFUL IN CANCER TREATMENT | BRITISH TECHNOLOGY GROUP LTD (GB) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020097-A1 | 17-SUBSTITUTED STEROIDS USEFUL IN CANCER TREATMENT | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-10-14 | — | — | WO | disclosed |
| US-4960539-A | Use of fluoromethylphenols as solvents for LC-polymers, and new fluoromethylphenols | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | disclosed |
| EP-0286953-B1 | USE OF FLUOROMETHYL PHENOLS AS SOLVENTS FOR LC POLYMERS, AND FLUOROMETHYL PHENOLS | BAYER AG (DE) | 1990-09-26 | — | — | EP | disclosed |
| EP-0286953-A1 | Use of fluoromethyl phenols as solvents for LC polymers, and fluoromethyl phenols | BAYER AG (DE) | 1988-10-19 | — | — | EP | disclosed |
| EP-0272533-A2 | Substituted phenoxypyridines | BAYER AG (DE) | 1988-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | SMN1; SMN2 1368/4885TSHR 4705/4885MEN1 3653/4885 |
| US-12029120-B2 | Organic electroluminescence element and electronic device | RPS10, H1-10, OR10J3 | SMN1; SMN2 3913/4885TSHR 3535/4885MEN1 1431/4885 |
| US-20240155942-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RPS10, H1-10, OR10J3 | SMN1; SMN2 3913/4885TSHR 3535/4885MEN1 1431/4885 |
| US-20240231222-A1 | PHOTORESIST COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE | ZKSCAN2, PIN1, CRY1 | SMN1; SMN2 3748/4885TSHR 2085/4885MEN1 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.